Literature DB >> 24814021

Differences in the reinstatement of ethanol seeking with ganaxolone and gaboxadol.

M J Ramaker1, M M Ford2, T J Phillips3, D A Finn3.   

Abstract

The endogenous neuroactive steroid allopregnanolone (ALLO) has previously been shown to induce reinstatement of ethanol seeking in rodents. ALLO is a positive allosteric modulator at both synaptic and extrasynaptic GABAA receptors. The contribution of each class of GABAA receptors in mediating reinstatement of ethanol seeking is unknown. The first aim of the present study was to determine whether ganaxolone (GAN), a longer-acting synthetic analog of ALLO, also promotes reinstatement of ethanol seeking. The second aim was to examine whether preferentially activating extrasynaptic GABAA receptors with the selective agonist gaboxadol (THIP) was sufficient to reinstate responding for ethanol in mice. Male C57BL/6J mice were trained to lever press for access to a 10% ethanol (v/v) solution (10E), using a sucrose-fading procedure. Following extinction of the lever-pressing behavior, systemic THIP (0, 4 and 6mg/kg) and GAN (0, 10, and 15mg/kg) were tested for their ability to reinstate ethanol-appropriate responding in the absence of 10E access. GAN significantly increased lever pressing on the previously active lever, while THIP did not alter lever-pressing behavior. The results of this study suggest that direct activation of extrasynaptic GABAA receptors at the GABA site is not sufficient to induce ethanol seeking in the reinstatement procedure. Future studies are necessary to elucidate the mechanisms and brain areas by which differences in the pharmacological activity of GAN and THIP at the GABAA receptor contribute to the dissimilarity in their effect on the reinstatement of ethanol seeking. Nonetheless, based on the increased use of these drugs in clinical trials across multiple disease states, the effects of GAN or THIP on alcohol seeking may be an important consideration if these drugs are to be used clinically in a population with a co-occurring alcohol use disorder.
Copyright © 2014 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  GABA(A) receptor; THIP; alcohol; allopregnanolone; extrasynaptic; relapse

Mesh:

Substances:

Year:  2014        PMID: 24814021      PMCID: PMC4122668          DOI: 10.1016/j.neuroscience.2014.04.065

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  61 in total

1.  GABA(A)-receptor delta subunit knockout mice have multiple defects in behavioral responses to ethanol.

Authors:  R M Mihalek; B J Bowers; J M Wehner; J E Kralic; M J VanDoren; A L Morrow; G E Homanics
Journal:  Alcohol Clin Exp Res       Date:  2001-12       Impact factor: 3.455

Review 2.  Stress and neuroactive steroids.

Authors:  M L Barbaccia; M Serra; R H Purdy; G Biggio
Journal:  Int Rev Neurobiol       Date:  2001       Impact factor: 3.230

3.  Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice.

Authors:  R M Mihalek; P K Banerjee; E R Korpi; J J Quinlan; L L Firestone; Z P Mi; C Lagenaur; V Tretter; W Sieghart; S G Anagnostaras; J R Sage; M S Fanselow; A Guidotti; I Spigelman; Z Li; T M DeLorey; R W Olsen; G E Homanics
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

4.  Allopregnanolone and pentobarbital infused into the nucleus accumbens substitute for the discriminative stimulus effects of ethanol.

Authors:  C W Hodge; M A Nannini; M F Olive; S P Kelley; K K Mehmert
Journal:  Alcohol Clin Exp Res       Date:  2001-10       Impact factor: 3.455

Review 5.  How does stress increase risk of drug abuse and relapse?

Authors:  R Sinha
Journal:  Psychopharmacology (Berl)       Date:  2001-10-26       Impact factor: 4.530

6.  Modification of behavioral effects of drugs in mice by neuroactive steroids.

Authors:  J T Ungard; M Beekman; M Gasior; R B Carter; D Dijkstra; J M Witkin
Journal:  Psychopharmacology (Berl)       Date:  2000-03       Impact factor: 4.530

7.  Chronic treatment with the neuroactive steroid ganaxolone in the rat induces anticonvulsant tolerance to diazepam but not to itself.

Authors:  D S Reddy; M A Rogawski
Journal:  J Pharmacol Exp Ther       Date:  2000-12       Impact factor: 4.030

8.  Alteration of voluntary ethanol and saccharin consumption by the neurosteroid allopregnanolone in mice.

Authors:  Rachna S Sinnott; Tamara J Phillips; Deborah A Finn
Journal:  Psychopharmacology (Berl)       Date:  2002-06-05       Impact factor: 4.530

9.  Sex differences in the effect of ethanol injection and consumption on brain allopregnanolone levels in C57BL/6 mice.

Authors:  D A Finn; R S Sinnott; M M Ford; S L Long; M A Tanchuck; T J Phillips
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

10.  Discriminative stimulus effects of ethanol in C57BL/6J and DBA/2J inbred mice.

Authors:  Keith L Shelton; Kathleen A Grant
Journal:  Alcohol Clin Exp Res       Date:  2002-06       Impact factor: 3.455

View more
  13 in total

1.  Effect of nucleus accumbens shell infusions of ganaxolone or gaboxadol on ethanol consumption in mice.

Authors:  Marcia J Ramaker; Moriah N Strong-Kaufman; Matthew M Ford; Tamara J Phillips; Deborah A Finn
Journal:  Psychopharmacology (Berl)       Date:  2014-10-25       Impact factor: 4.530

2.  Site-specific microinjection of Gaboxadol into the infralimbic cortex modulates ethanol intake in male C57BL/6J mice.

Authors:  Brandon M Fritz; Stephen L Boehm
Journal:  Behav Brain Res       Date:  2014-07-18       Impact factor: 3.332

3.  Null mutation of 5α-reductase type I gene alters ethanol consumption patterns in a sex-dependent manner.

Authors:  Matthew M Ford; Jeffrey D Nickel; Moriah N Kaufman; Deborah A Finn
Journal:  Behav Genet       Date:  2014-11-23       Impact factor: 2.805

4.  Effects of Gabra2 Point Mutations on Alcohol Intake: Increased Binge-Like and Blunted Chronic Drinking by Mice.

Authors:  Emily L Newman; Georgia Gunner; Polly Huynh; Darrel Gachette; Stephen J Moss; Trevor G Smart; Uwe Rudolph; Joseph F DeBold; Klaus A Miczek
Journal:  Alcohol Clin Exp Res       Date:  2016-09-26       Impact factor: 3.455

5.  Differential interactions engendered by benzodiazepine and neuroactive steroid combinations on schedule-controlled responding in rats.

Authors:  Barak W Gunter; Donna M Platt; James K Rowlett
Journal:  Pharmacol Biochem Behav       Date:  2015-08-06       Impact factor: 3.533

Review 6.  A Rationale for Allopregnanolone Treatment of Alcohol Use Disorders: Basic and Clinical Studies.

Authors:  A Leslie Morrow; Giorgia Boero; Patrizia Porcu
Journal:  Alcohol Clin Exp Res       Date:  2019-12-17       Impact factor: 3.455

7.  Dynamic Adaptation in Neurosteroid Networks in Response to Alcohol.

Authors:  Deborah A Finn; Vanessa A Jimenez
Journal:  Handb Exp Pharmacol       Date:  2018

8.  Activation of extrasynaptic δ-GABAA receptors globally or within the posterior-VTA has estrous-dependent effects on consumption of alcohol and estrous-independent effects on locomotion.

Authors:  Laverne C Melón; Zachary T Nolan; Delphine Colar; Eileen M Moore; Stephen L Boehm
Journal:  Horm Behav       Date:  2017-09-20       Impact factor: 3.587

9.  Ceftriaxone and cefazolin attenuate the cue-primed reinstatement of alcohol-seeking.

Authors:  Ana Weiland; Steven Garcia; Lori A Knackstedt
Journal:  Front Pharmacol       Date:  2015-03-10       Impact factor: 5.810

Review 10.  Immune treatments for alcohol use disorder: A translational framework.

Authors:  Lindsay R Meredith; Elizabeth M Burnette; Erica N Grodin; Michael R Irwin; Lara A Ray
Journal:  Brain Behav Immun       Date:  2021-07-31       Impact factor: 19.227

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.